Search results
ERS Genomics and IRBM sign CRISPR / Cas9 license agreement
BioPharma-Reporter· 22 hours agoCRISPR licensing company ERS Genomics and drug discovery firm IRBM have entered into a non-exclusive...
Is CRISPR Therapeutics Stock a Buy? | The Motley Fool
The Motley Fool· 4 days agoCRISPR Therapeutics (CRSP -1.40%) is a star in the gene-editing therapy niche. The company made...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 0.3%
ETF DAILY NEWS· 2 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report)’s stock price dropped 0.3% during mid-day trading on Friday . The company traded as low as $54.64 and last traded at ...
New CRISPR screening method could reveal what drives brain diseases
Medical Xpress· 13 hours agoThe method, outlined in a study published in Cell on May 20, 2024, provides a way to rapidly examine the brain cell types linked to key developmental genes at a scale never done before—helping ...
CRISPR can treat common form of inherited blindness, early data hint
LiveScience· 6 days agoA CRISPR therapy injected directly into the eye shows promise in treating the most common form of...
Cathie Wood Pulls the Trigger on These 2 ‘Strong Buy’ Stocks
TipRanks via Yahoo Finance· 5 hours agoCathie Wood is famous for her singular investing style. Favoring high growth and disruptors, she...
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 6 days agoCRISPR Therapeutics (NASDAQ: CRSP) closed last week down 8.5% after reporting first-quarter...
Cathie Wood's Ark Invest Buys Shares Of Nvidia-Rival AMD, Continues Its Shopify Share-Buying Spree -...
Benzinga· 4 hours agoArk Invest’s ARK Genomic Revolution ETF (ARKG) sold shares of Exact Sciences Corp (EXAS). Ark...
BLUE vs. CRSP: Why Are These Stocks Moving in Opposite Directions?
TipRanks via Yahoo Finance· 3 days agoLast week, Bluebird Bio (NASDAQ:BLUE) shares climbed while CRISPR Therapeutics (NASDAQ:CRSP) stock...
How Gene Editing Therapies Could Go Beyond Rare Diseases
Forbes· 5 days agoEarlier this year, a group of scientists in the Netherlands used the gene editing tool CRISPR to...